Yumanity Therapeutics' Series A Round

Yumanity Therapeutics raised a round of funding on February 10, 2016.

Yumanity Therapeutics, founded in 2014, specializes in drug discovery for neurodegenerative diseases caused by protein misfolding. The company is mainly focused on discovering disease-modifying therap…

Articles about Yumanity Therapeutics' Series A Round: